Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa - Bhuvan P. Raval - 書籍 - LAP LAMBERT Academic Publishing - 9783659445736 - 2013年8月16日
カバー画像とタイトルが一致しない場合、正しいのはタイトルです

Global Medical Device Regulation: Emphasis on Active Implants: Usfda, Emea and Anvisa

価格
¥ 8.856
税抜

遠隔倉庫からの取り寄せ

発送予定日 年11月18日 - 年11月30日
クリスマスプレゼントは1月31日まで返品可能です
Bhuvan P. Raval の新しいリリースのお知らせを受け取る
iMusicのウィッシュリストに追加

まだ評価がありません

Regulations for medical devices in EU Member countries are governed by European Medicine Evaluation Authority, popularly known as EMEA. As per EMEA's guideline each member country has to strictly follow the common guidelines with exception to rules and regulation that are modified by state authorities but must be in conformity with EMEA Guideline. Regulations posed in here are further divided in implantable and active implantable medical devices thereafter where manufacturing, testing and distribution can only be done once it is CE marked. In case of non CE marked devices i.e. non-EU member manufacturer, market authorisation process shall be completed prior to approval and separately. For brazil market that is governed by ANVISA, medical devices are classified into four different classes. There is no independent discrimination made for Active implantable medical devices but most non invasive devices are covered in Class I. While those which are to be connected with blood storage and other devices are classified into class II. Class III devices are those which are connected or included with wounds or healthy tissues.

メディア 書籍     Paperback Book   (ソフトカバーで背表紙を接着した本)
リリース済み 2013年8月16日
ISBN13 9783659445736
出版社 LAP LAMBERT Academic Publishing
ページ数 144
寸法 150 × 9 × 226 mm   ·   233 g
言語 ドイツ語  

Bhuvan P. Ravalの他の作品を見る